Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.55 USD
Change Today -0.0099 / -1.77%
Volume 62.9K
CYCC On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Spiro George Rombotis

Chief Executive Officer, President and Executive Director,Cyclacel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 38 board members in 2 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Spiro George Rombotis has been President of Cyclacel Pharmaceuticals Inc. (formerly, Cyclacel Group Plc) since August 1997 and has been its Founding Chief Executive Officer since joining in August 1997. Mr. Rombotis also serves as Chief Executive of Cyclacel Limited. He has over 23 years of experience with pharmaceutical and biotechnology companies. He served as Chief Executive Officer and President of Xcyte Therapies Inc. Previously, he served as Vice President ...

Read Full Background

Corporate Headquarters*

200 Connell Drive
Berkeley Heights, New Jersey 07922

United States

Phone: 908-517-7330
Fax: 866-271-3466

Board Members Memberships*

Chief Executive Officer, President and Executive Director


Williams College
Master's Degree
J.L. Kellogg School of Management, Northwestern University
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$530,553

Stock Options*

All Other Compensation$27,808
Exercisable Options134,735
Unexercisable Options67,812
Total Number of Options202,547

Total Compensation*

Total Annual Cash Compensation$558,361
Total Short Term Compensation$530,553
Other Long Term Compensation$27,808
Total Calculated Compensation$558,361
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $0.55 USD -0.0099


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at